Výsledky vyhledávání - "Maiko Fukushima"

Akademický článek

Prevalence of pregnancy- and lactation-associated osteoporosis in the postpartum period: A systematic review and meta-analysis.

Autor: Maiko Fukushima¹, Maiko Kawajiri² maiko.kawajiri.c4@tohoku.ac.jp, Mikako Yoshida², Yoko Takeishi², Yasuka Nakamura³, Toyoko Yoshizawa⁴

Publikováno v: Drug Discoveries & Therapeutics. Aug2024, Vol. 18 Issue 4, p220-228. 9p.

Zobrazit plný text záznamu

Circulating CD4+PD-1+ and CD8+PD-1+ T cells are profoundly decreased at the onset of fulminant type 1 diabetes and are restored by treatment, contrasting with CD4+CD25+FoxP3+ regulatory T cells

Autor: Maiko Fukushima, Toshie Iijima, Teruo Jojima, Takanori Tomotsune, Kunihiro Suzuki, Yoshimasa Aso, Kanako Kato

Publikováno v: Diabetes research and clinical practice. 133

Programed cell death protein-1 (PD-1) is an inhibitory receptor expressed by T cells that downregulates the activation and proliferation of these cells to maintain peripheral self-tolerance. Recent studies reported some cases of new-onset type 1 diab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b4df566bf899f971d90ed96ed1d9c6f
https://pubmed.ncbi.nlm.nih.gov/28869918

Zobrazit plný text záznamu

Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+ T cells in patients with type 2 diabetes

Autor: Atsushi Momobayashi, Masaaki Sagara, Teruo Jojima, Toshihiko Inukai, Kikuo Kasai, Kunihiro Suzuki, Yoshimasa Aso, Maiko Fukushima, Toshie Iijima

Publikováno v: Diabetes research and clinical practice. 110(3)

Objective CD26/DPP-4 is highly expressed by T cells, especially CD4+ T cells (T helper cells; Th) and may regulate the differentiation, maturation, or proliferation of these cells. We investigated the effects of sitagliptin, a DPP-4 inhibitor, on the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b01b289838d75dace2e78be6b0b0c9b
https://pubmed.ncbi.nlm.nih.gov/26508675

Zobrazit plný text záznamu

Bezafibrate, a peroxisome proliferator-activated receptor α agonist, decreases circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetes

Autor: Tomoko Terasawa, Atsushi Momobayashi, Maiko Fukushima, Toshihiko Inukai, Yoshimasa Aso, Kyoko Omori

Publikováno v: Translational research : the journal of laboratory and clinical medicine. 165(2)

CD14(+)CD16(+) monocytes are proinflammatory cells that produce tumor necrosis factor and interleukin (IL)-1β. The number of circulating CD14(+)CD16(+) monocytes is increased in patients with chronic renal failure or coronary artery disease. We inve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdd5be4929e4dade942881ab8c9b97f7
https://pubmed.ncbi.nlm.nih.gov/25134759

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání